Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 589-592

  Blank, M ^a,b   Shani, A ^a,b   Goldberg, I ^a   Kopolovic, J ^a   Amigo, M C ^c   Magrini, L ^d   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiphospholipid syndrome; Beta 2 glycoprotein I; Libman Sacks endocarditis; Synthetic peptides

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; BETA2 GLYCOPROTEIN 1; BIOTIN; PEROXIDASE; PHOSPHOLIPID ANTIBODY; STREPTAVIDIN; SYNTHETIC PEPTIDE; THREONYLLEUCYLARGINYLVALYLTYROSYLLYSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; BACTERIUM; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCARDITIS; ENZYME ANALYSIS; HEART VALVE; HUMAN; INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; VIRUS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ENDOCARDITIS; EPITOPES; GLYCOPROTEINS; HEART VALVES; HUMANS; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; PEPTIDES; PROTEIN BINDING;

EID: 7044247340     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.06.039     Document Type: Conference Paper

References (30)

1. G.R.V. Hughes, E.N. Harris, and A.E. Gharavi The anti-cardiolipin syndrome J. Rheumatol. 13 1986 486 489
2. R.A. Asherson, R. Cervera, J.C. Piette, and Y. Shoenfeld Milestones in the antiphospholipid syndrome R.A. Asherson R. Cervera J.C. Piette Y. Shoenfeld The antiphospholipid syndrome II-autoimmune thrombosis 2002 Elsevier Amsterdam
3. M. Galli, P. Comfurious, C. Massen, M.H. Hemker, P.J. Be-Bates, and P. van-Breda Anti-cardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1990 1544 1547
4. Y. Shoenfeld Systemic antiphospholipid syndrome Lupus 12 2003 497 498
5. R. Cervera, J.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, and M.T. Camps Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum. 46 2002 1019 1027
6. R.A. Asherson, and R. Cervera Unusual manifestations of the antiphospholipid syndrome Clin. Rev. Allergy Immunol. 25 2003 61 78
7. E. Libman, and B.A. Sacks Hitherto undescribed from of valvular and mural endocarditis Arch. Intern. Med. 33 1924 701 737
8. R.F. Shapiro, C.N. Gamble, and K.B. Weisner Immunoparhogenesis of Libman-Sacks endocarditis Ann. Rheum. Dis 36 1977 508 516
9. J.G. D'alton, D.N. Preston, J. Bormanis, M.S. Green, and G.R. Kroog Multiple transient ischemic attacks, lupus anticoagulant and verucous endocarditis Stroke 16 1985 512 514
10. R.A. Asherson, and G.R.V. Hughes The expanding spectrum of Libman Sacks endocarditis; the role of anti-phospholipid antibodies Clin. Exp. Rheumatol. 7 1989 225 228
11. E.K. Chartash, D.M. Lans, S.A. Paget, T. Qamar, and M.D. Lockshin Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome Am. J. Med. 86 1989 407 412
12. M.A. Khamashta, A. Gil, R.A. Asherson, J.J. Vazques, and G.R.V. Hughes Antiphospholipid antibodies, valvular heart disease, and systemic lupus erythematosus Am. J. Med. 86 1989 633 634
13. K.V. Straaton, W.W. Chatham, S.H. Smith, and W.J. Koopman Clinically significant valvular heart disease in systemic lupus erythematosuse Am. J. Med. 85 1988 645 650
14. M.A. Khamashta, R. Cervera, R.A. Asherson, J. Font, A. Gil, and D.J. Coltart Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus Lancet 335 1990 1541 1544
15. L. Ziporen, I. Goldberg, M. Arad, M. Hojnik, J. Ordi-Ros, and A. Afek Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves Lupus 5 1996 196 205
16. A. Afek, Y.Y. Shoenfeld, R. Manor, I. Goldberg, L. Ziporen, and J. George Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome Lupus 8 1999 502 507
17. E. Matsuura, Y. Igarashi, T. Yasuda, D.A. Triplett, and T. Koike Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface J. Exp. Med. 179 1994 457 462
18. S. Horkko, E. Miller, D.W. Branch, W. Palinski, and J.L. Witztum The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins) Proc. Natl. Acad. Sci. U. S. A. 94 1997 10356 10361
19. J.S. Levine, D.W. Branch, and J. Rauch The antiphospholipid syndrome N. Engl. J. Med. 346 2002 752 763
20. J. Rauch, R. Subang, P. D'Agnillo, J.S. Koh, and J.S. Levine Apoptosis and the antiphospholipid syndrome J. Autoimmun. 15 2000 231 235
21. M. Sorice, A. Circella, R. Misasi, V. Pittoni, T. Garofalo, and A. Cirelli Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies Clin. Exp. Immunol. 122 2000 277 284
22. B.A. Cocca, S.N. Seal, P. D'Agnillo, Y.M. Mueller, P.D. Katsikis, and J. Rauch Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells Proc. Natl. Acad. Sci. U. S. A. 98 2001 13826 13831
23. G.A. Prieto, A.R. Cabral, M. Zapata-Zuniga, A.J. Simon, A.R. Villa, and D. Alarcon-Segovia Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies Arthritis Rheum. 48 2003 471 474
24. M. Blank, I. Krause, M. Fridkin, N. Keller, J. Kopolovic, and I. Goldberg Bacterial induction of autoantibodies to β2glycoprotein I accounts for the infectious etiology of antiphospholipid syndrome J. Clin. Invest. 106 2002 797 804
25. Y. Shoenfeld Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unraveled Trends Immunol. 24 2003 2 4
26. A.E. Gharavi, S.S. Pierangeli, R.G. Espinola, X. Liu, M. Colden-Stanfield, and N.E. Harris Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo Arthritis Rheum. 46 2002 545 552
27. A.E. Gharavi, M. Vega-Ostertag, R.G. Espinola, X. Liu, L. Cole, and N.T. Cox Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL Abs Lupus 13 2004 17 23
28. S.S. Pierangeli, M. Blank, X. Liu, R. Espinola, M. Fridkin, and M.V. Ostertag A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid Abs in vivo J. Autoimmun. 22 2004 217 225
29. M. Blank, Y. Shoenfeld, S. Cabilli, Y. Heldman, M. Fridkin, and E. Katchalski-Katzir Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides Proc. Natl. Acad. Sci. U. S. A. 96 1999 5164 5168
30. Y. Shoenfeld, I. Krause, F. Kvapil, J. Sulkes, S. Lev, and P. vonLandenberg Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome J. Clin. Immunol. 23 2003 377 383